GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Orthofix Medical Inc (FRA:OM2) » Definitions » Days Sales Outstanding

Orthofix Medical (FRA:OM2) Days Sales Outstanding : 61.27 (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is Orthofix Medical Days Sales Outstanding?

Orthofix Medical's average Accounts Receivable for the three months ended in Mar. 2024 was €116.5 Mil. Orthofix Medical's Revenue for the three months ended in Mar. 2024 was €173.5 Mil. Hence, Orthofix Medical's Days Sales Outstanding for the three months ended in Mar. 2024 was 61.27.

The historical rank and industry rank for Orthofix Medical's Days Sales Outstanding or its related term are showing as below:

FRA:OM2' s Days Sales Outstanding Range Over the Past 10 Years
Min: 51.02   Med: 58.1   Max: 71.48
Current: 57

During the past 13 years, Orthofix Medical's highest Days Sales Outstanding was 71.48. The lowest was 51.02. And the median was 58.10.

FRA:OM2's Days Sales Outstanding is ranked better than
60.77% of 808 companies
in the Medical Devices & Instruments industry
Industry Median: 65.27 vs FRA:OM2: 57.00

Orthofix Medical's Days Sales Outstanding increased from Mar. 2023 (51.32) to Mar. 2024 (61.27).


Orthofix Medical Days Sales Outstanding Historical Data

The historical data trend for Orthofix Medical's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Orthofix Medical Days Sales Outstanding Chart

Orthofix Medical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Days Sales Outstanding
Get a 7-Day Free Trial Premium Member Only Premium Member Only 64.57 75.17 57.30 62.00 52.16

Orthofix Medical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Days Sales Outstanding Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 51.32 55.38 55.73 55.71 61.27

Competitive Comparison of Orthofix Medical's Days Sales Outstanding

For the Medical Devices subindustry, Orthofix Medical's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Orthofix Medical's Days Sales Outstanding Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Orthofix Medical's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Orthofix Medical's Days Sales Outstanding falls into.



Orthofix Medical Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Orthofix Medical's Days Sales Outstanding for the fiscal year that ended in Dec. 2023 is calculated as

Days Sales Outstanding (A: Dec. 2023 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2022 ) + Accounts Receivable (A: Dec. 2023 )) / count ) / Revenue (A: Dec. 2023 )*Days in Period
=( (78.217 + 117.466) / 2 ) / 684.67*365
=97.8415 / 684.67*365
=52.16

Orthofix Medical's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

Days Sales Outstanding (Q: Mar. 2024 )
=Average Accounts Receivable /Revenue*Days in Period
=( (Accounts Receivable (A: Dec. 2023 ) + Accounts Receivable (A: Mar. 2024 )) / count ) / Revenue (A: Mar. 2024 )*Days in Period
=( (117.466 + 115.568) / 2 ) / 173.519*365 / 4
=116.517 / 173.519*365 / 4
=61.27

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Orthofix Medical  (FRA:OM2) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.


Orthofix Medical Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Orthofix Medical's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.


Orthofix Medical (FRA:OM2) Business Description

Traded in Other Exchanges
Address
3451 Plano Parkway, Lewisville, TX, USA, 75056
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two main segments: global spine, including bone growth and healing therapies, spinal implants, and regenerative tissue products; and global orthopedics, providing products used in fracture repair, deformity correction, and bone reconstruction procedures. The majority of the company's sales come from the global spine segment in the United States. Orthofix distributes its products throughout North America, Europe, and several countries globally. The company provides solutions to hospitals, physicians, other healthcare providers, and patients.

Orthofix Medical (FRA:OM2) Headlines

No Headlines